EDEN PRAIRIE, Minn., Jan. 5 /PRNewswire/ -- Inlet Medical Inc., a privately held medical device company that develops and markets specialty laparoscopic surgical products, has launched the Carter-Thomason(R) CloseSure System XL(TM) in the United States. The CloseSure System XL combines a Pilot(R) guide and suture passer to ensure complete wound closure after laparoscopic surgery and prevent post-surgical herniation in obese patients, a common complication among these patients. Laparoscopic surgery, performed through several small incisions, is growing in this patient group with the rise in bariatric surgery as a treatment for obesity. The CloseSure System XL is based on the company's innovative Carter-Thomason CloseSure(TM) System, which has been on the market since 1998, and has a 100 percent success rate.
"As the number of obese patients increases, physicians require specialized surgical tools to ensure the best possible outcomes for this challenging patient group," said Lee Jones, president and chief executive officer, Inlet Medical. "The Carter-Thomason CloseSure System XL offers physicians and patients significant benefits in various laparoscopic procedures, particularly bariatric surgery to treat obesity -- a rapidly growing procedure. With this surgical system, physicians can close incisions completely, prevent herniation at the site and improve outcomes without extending surgical time."
Herniation, or a rupture of muscle tissue, is a relatively common complication of laparoscopic surgery, and obese patients have a greater risk of developing hernias at an incision site. Full-thickness closure of the four layers of the abdominal wall prevents this problem. Hand suturing is especially difficult in obese patients, and the Carter-Thomason CloseSure System XL puts full-thickness closure within reach for these patients.
One in four Americans is considered obese and an estimated 400,000 people died of obesity-related complications in 2000. The number of bariatric procedures is increasing rapidly, with a majority now performed laparoscopically. According to the American Society of Bariatric Surgeons, 63,000 bariatric surgeries were performed in 2002, 15 percent of which were laparoscopic. In 2005, an estimated 250,000 procedures will be performed with 85 percent completed laparoscopically.
Recently, the Carter-Thomason Closure System XL was named the 2004 Innovative Product of the Year by the Society of Laparoendoscopic Surgeons. Inlet Medical also markets a line of laparoscopic gynecology products for pelvic support procedures. The CloseSure System is also used in conjunction with these procedures.
About Inlet Medical Inc.
Inlet Medical Inc., based in Eden Prairie, Minn., is a privately held medical device company that specializes in laparoscopic surgical products. The company develops and markets to laparoscopic surgeons who perform more than 2 million procedures annually. More information about the company can be found at http://www.inletmedical.com/ . Educational information about the procedures is available at http://www.inletmedical.org/ .
Inlet Medical Inc.
CONTACT: Lee Jones, President and CEO of Inlet Medical Inc.,+1-952-942-5034, or firstname.lastname@example.org ; or Nancy A. Johnson,+1-612-455-1745, or email@example.com , or Laura Spitzack, +1-612-455-1782,or firstname.lastname@example.org , both of Padilla Speer Beardsley Inc.